Home/Filings/4/0000899243-21-003518
4//SEC Filing

Matthews Judith M. 4

Accession 0000899243-21-003518

CIK 0001659323other

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 7:32 PM ET

Size

6.9 KB

Accession

0000899243-21-003518

Insider Transaction Report

Form 4
Period: 2021-01-25
Matthews Judith M.
Chief Financial Officer
Transactions
  • Award

    Ordinary Shares

    2021-01-25+62,50062,500 total
  • Sale

    Ordinary Shares

    2021-01-26$1.73/sh33,868$58,59228,632 total
Footnotes (2)
  • [F1]Consists of 62,500 ordinary shares received upon vesting of performance-based stock units ("PSUs") on January 25, 2021, which PSUs were subject to performance conditions that have been satisfied. PSUs convert into ordinary shares on a one-for-one basis.
  • [F2]Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the PSUs. This sale does not represent a discretionary trade by the reporting person.

Issuer

Iterum Therapeutics plc

CIK 0001659323

Entity typeother

Related Parties

1
  • filerCIK 0001734033

Filing Metadata

Form type
4
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 7:32 PM ET
Size
6.9 KB